ISSN: 2161-0460

Revista de enfermedad de Alzheimer y parkinsonismo

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Claves Académicas
  • TOC de revistas
  • Infraestructura Nacional del Conocimiento de China (CNKI)
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

The Relationship between Choline Acetyltransferase and Nitric Oxide Synthase Isoform Expression in Alzheimer's Disease

B.E. Kalisch *,J.C. Baskey ,R.J. Rylett

Nitric oxide (NO) plays an important role in cholinergic neurotransmission and has been implicated in the progression of Alzheimer’s disease (AD). Cholinergic neurotransmission has been associated with regulation of NO synthase (NOS) expression, and we determined previously that NO modulates choline acetyltransferase (ChAT) expression. In spite of the important links identified between NOS and ChAT, little is known about the relationship between these two enzymes in AD. Therefore in the present study, we compared the expression levels of ChAT and NOS in necropsy brain of individuals with AD and non-demented controls. ChAT and NOS levels were assessed in control and AD caudate, nucleus basalis of Meynert (nbM), cortex and hippocampus by radioenzymatic assay, immunoblot analysis and RT-PCR. We detected a significant decrease in ChAT activity in the cortex of AD cases, but no alterations in NOS activity were observed in any of the brain regions examined. At the mRNA level, no significant decrease in total ChAT mRNA was detected but the decrease in M-ChAT mRNA levels approached significance in the nbM. No difference in nNOS and iNOS mRNA and protein levels was observed between control and AD tissue in any of the four brain regions sampled, but a statistically significant decrease in eNOS mRNA levels was detected in both the cortex and hippocampus of AD brain. Finally, the levels of ChAT and NOS activity, protein or mRNA isoforms did not correlate in most of the brain regions examined, but a reduction in ChAT activity and eNOS mRNA in basal forebrain projection regions was observed. These data suggest that in general, there is no correlation between the levels of NOS and ChAT in control or AD subjects, but a reduction in eNOS levels in the hippocampus and cortex indicates there could be an interaction between eNOS containing cells and basal forebrain projections neurons in AD.